Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy (Q82976088)
scientific article published on 01 May 2006
Language:
(P31) (Q13442814)
(P50) (Q57840070)
(P304) 2005-2011
(P433) 9
(P478) 106
(P577) Monday, May 1, 2006
(P921) (Q6934595)
(Q42824440)
(Q18975855)
(Q274160)
(Q177094)
(P1433) (Q326041)
(P1476) "Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy" (language: en)
(P2093) Ken Wyman
Michael B Atkins
Victor Prieto
David F McDermott
Francie Hubbard
Christine Byrnes
Kathleen Sanders
Jeffrey A Sosman
(P2860) (Q40738758)
(Q73181804)
(Q33336718)
(Q43899710)
(Q29618610)
(Q40399915)
(Q35927852)
(Q24337545)
(Q36366794)
(Q24300451)
(Q29614282)
(Q50790101)
(Q44594958)
(Q43797374)
(Q44189518)
(Q40814460)
(Q27860904)
(Q46412217)
(Q28277030)
(Q27824812)
(Q27861059)
(Q40580619)
(Q36616712)
(Q27860760)
other details
description scientific article published on 01 May 2006

External Links